Last updated: August 17, 2026
Stem cells and cancer stem cells possess an extraordinary ability to enter a dormant state, characterized by a reversible suspension of proliferation and metabolic activity. This phenomenon, known as dormancy, plays a crucial role in tissue homeostasis, regeneration, and the development and progression of cancer. Understanding the mechanisms underlying dormancy is essential for harnessing its therapeutic potential and developing effective strategies to combat cancer.
Dormancy in Stem Cells: A Complex Mechanism
Stem cells are unspecialized cells capable of self-renewal and differentiation into various specialized cell types. Dormancy in stem cells is a tightly regulated process influenced by intrinsic and extrinsic factors, including cell cycle regulators, signaling pathways, and microenvironmental cues. During dormancy, stem cells maintain their self-renewal capacity while suspending proliferation and metabolic activity. This quiescent state allows stem cells to persist in a protective environment, evading cellular stress and DNA damage.
Cancer Stem Cells and Dormancy: Unraveling the Enigma
Cancer stem cells (CSCs) are a subpopulation of cancer cells that possess stem cell-like properties, including self-renewal and differentiation potential. CSCs are often associated with tumor initiation, metastasis, and resistance to therapy. Dormancy plays a significant role in CSC biology. CSCs can enter dormancy in response to various stimuli, such as chemotherapy or radiation therapy. In this dormant state, CSCs are resistant to treatment and can persist for extended periods, leading to tumor recurrence and metastasis.
Therapeutic Implications of Dormancy in Stem Cells and Cancer Stem Cells
Understanding dormancy in stem cells and CSCs has important therapeutic implications. In the context of stem cell transplantation, strategies to manipulate dormancy could enhance engraftment and reduce graft-versus-host disease. Conversely, in cancer therapy, targeting dormant CSCs could prevent tumor recurrence and metastasis. Research efforts are underway to develop novel therapeutic approaches that selectively target dormant CSCs, such as small molecule inhibitors or immunotherapies.
Dormancy in stem cells and CSCs is a complex and dynamic process that influences tissue homeostasis, cancer progression, and therapeutic outcomes. Unraveling the molecular mechanisms underlying dormancy is essential for harnessing its therapeutic potential. By understanding the factors that regulate dormancy, we can develop innovative strategies to promote stem cell engraftment, enhance tissue regeneration, and effectively combat cancer.
Scientific Evidence
Research in stem cells and cellular technologies continues to develop across regenerative medicine, immunology and tissue repair. The strength of evidence differs considerably between cell types, medical conditions and treatment protocols. Laboratory findings, early clinical studies and established therapeutic applications should therefore be evaluated separately. Any clinical decision should be based on the patient’s diagnosis, current medical status, available evidence and the regulatory framework applicable in the country of treatment.
Scientific Evidence
Research in stem cells and cellular technologies continues to develop across regenerative medicine, immunology and tissue repair. The strength of evidence differs considerably between cell types, medical conditions and treatment protocols. Laboratory findings, early clinical studies and established therapeutic applications should therefore be evaluated separately. Any clinical decision should be based on the patient’s diagnosis, current medical status, available evidence and the regulatory framework applicable in the country of treatment.
Extracellular Vesicles and Exosomes
Extracellular vesicles, including populations commonly described as exosomes, are being investigated as mediators of intercellular communication and paracrine activity. Their biological properties depend on the source cells, isolation method, characterization, concentration and storage conditions. Measurements expressed only as particle numbers do not provide a complete assessment of identity, purity or potency. Clinical claims should therefore be distinguished carefully from laboratory research and early-stage clinical evidence.
Extracellular Vesicles and Exosomes
Extracellular vesicles, including populations commonly described as exosomes, are being investigated as mediators of intercellular communication and paracrine activity. Their biological properties depend on the source cells, isolation method, characterization, concentration and storage conditions. Measurements expressed only as particle numbers do not provide a complete assessment of identity, purity or potency. Clinical claims should therefore be distinguished carefully from laboratory research and early-stage clinical evidence.
Scientific Case Review
Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?
Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.
- Review of the information you provide
- Relevant research and clinical program information
- A clear response focused on your situation
No obligation. Your question will be reviewed confidentially.
Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.
